Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Recruiting now · Phase 1/Phase 2
Conditions studied: Diabetes
In brief
The intervention in this trial is intraocular islet transplantation. A single dose of 1000 - 3000 Islet Equivalents (IEQ)/kg recipient body weight (BW) will be infused into the anterior chamber of the eye through a self-sealing incision in the peripheral cornea. The procedure is projected to take approximately 20-30 minutes. Transplant recipients in this study will receive localized maintenance immunosuppression via topical application of eye-drops.
Key facts
- Study ID
- NCT02846571
- Run by
- Midhat H. Abdulreda
- People needed
- 2
- Starts
- 2019-12-05
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-03-12
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Bascom Palmer Eye Institute — Miami, Florida, United States (enrolling)
- Diabetes Research Institute, University of Miami Miller School of Medicine — Miami, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.